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Mast cells (MCs) are best known for eliciting harmful
reactions, mostly after primary immunity has been
established. Here, we report that, during footpad
infection with E. coli in MC-deficient mice, as
compared to their MC-sufficient counterparts, the
serum antibody response is significantly diminished
and less protective following passive immunization
in a urinary tract infection (UTI) model in wild-type
mice. MCs were found to recruit large numbers of
dendritic cells (DCs) into the infected tissue site,
which eventually migrated into draining lymph nodes
(DLNs) during a prolonged time course. This pattern
of trafficking was facilitated by MC-generated TNF,
which increased the expression of E-selectin on
local blood vessels. Antibody blockade of E-selectin
inhibited DC recruitment into the site of infection
and DLNs and consequently impaired the primary
humoral immune response. Thus, during infection,
resident MCs contribute to the primary protective
adaptive response through recruitment of DCs from
the circulation into infected sites.
INTRODUCTION
Mast cells (MCs) are well established as mediators in a variety of
pathological conditions. For example, MCs are the principle
effector cells responsible for the hives, eczema, hay fever, and
asthma associated with IgE-mediated inflammatory reactions
to further allergen exposure (Galli, 2000). However, in spite of
the wealth of literature supporting their adverse effects, there
is growing evidence that MCs contribute to the early and protec-
tive immune responses to microbial infection (Marshall, 2004).
MCs are preferentially located at host-environment interfaces
where they can encounter invading pathogens. Interactions
with pathogens or pathogen products induce MCs to rapidlyCell Hosrelease a myriad of prestored and de novo synthesized media-
tors (Gurish and Austen, 2001) that facilitate the recruitment of
various immune cells to sites of infection or to distal nodes drain-
ing these sites. For instance, the rapid neutrophil response to
different Gram-positive and Gram-negative bacterial infections
has been linked to MC activation (Echtenacher et al., 1996;
Malaviya et al., 1994; Mullaly and Kubes, 2006; Siebenhaar
et al., 2007; Supajatura et al., 2001). In addition, MC release of
these mediators has been implicated in the enhanced influx
and sequestration of T cells into distal draining lymph nodes
(DLNs) following infection (McLachlan et al., 2003). The extrava-
sation of circulating naive T cells into DLN is triggered when
MC-derived TNF percolates from the periphery into the nodes
via lymphatic vessels (McLachlan et al., 2003). In spite of their
potential to mobilize key immune cells during infection, a role
for MCs in the development of the primary adaptive immune
responses to pathogens has yet to be demonstrated.
Recently, several independent studies relating to vaccine
development have reported reduced adaptive immune re-
sponses in MC-deficient mice after administration of various
adjuvant compounds, including smallMC-activating compounds
(McLachlan et al., 2008), the TLR7 agonist imiquimod (Heib et al.,
2007), or complete Freund’s adjuvant (Gregory et al., 2005).
Cumulatively, these observations point to a role for MCs in the
development of primary adaptive immune responses. In some
of these studies,MCactivationwas linked to enhancedmigration
of DCs from sites of vaccine delivery to the DLNs (Heib et al.,
2007; McLachlan et al., 2008).
Dendritic cells (DCs) are potent antigen-presenting cells
known to transport antigens from peripheral tissues to T-cell-
rich zones of secondary lymphoid tissue (Banchereau and Stein-
man, 1998). DC accumulation in DLNs is closely associated with
a massive influx of naive lymphocytes, a response that is func-
tionally associated with optimal T-cell-dependent immune
responses (MartIn-Fontecha et al., 2003). It has also been shown
that MCs promote the migration of epidermal Langerhans cells
(LCs), a subset of DCs, following IgE-mediated activation (Bryce
et al., 2004; Jawdat et al., 2004). These studies raise the possi-
bility that DCs may be mobilized by MCs to DLNs duringt & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc. 331
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Figure 1. MCs Are Required for the Maximal
Induction of a Protective Primary Humoral
Response to E. coli
(A) GMT of TNP-specific serum IgG inWT andMC-
deficient Wsh/Wsh (Wsh) mice 14 days after injec-
tion with 1 3 106 TNP-labeled E. coli. n = 9–11.
*p < 0.05 compared to Wsh mice using unpaired
Student’s t test.
(B) The number of E. coli colony-forming units
(CFU) per bladder of WT mice that received 150
ml serum from naive or TNP E. coli-immunized
WT or Wsh mice. n = 9–11. *p < 0.05 comparing
responses in recipient mice that received serum
from naive or E. coli-challenged mice; **p < 0.05
comparing the responses between recipient mice
that received serum from E. coli-challenged WT
and Wsh mice.
(C) GMT of TNP-specific serum IgG in WT, MC-
deficient W/Wv, and footpad WT-MC-repleted
W/Wv mice injected with 1 3 106 TNP-labeled
E. coli. n = 12 for WT, n = 14 for W/Wv, and n = 5
for WT-MC reconstituted W/Wv samples. *p =
0.001 compared to W/Wv mice.
(D) GMT of TNP-specific serum IgG in footpad
WT-MC-repleted or TNF/ MC-repleted W/Wv
mice injected with 1 3 106 TNP-labeled E. coli.
n = 5 for each group. *p = 0.001.
Data in (B)–(D) were analyzed for statistical signifi-
cance with one-way ANOVA and Tukey’s posttest.
Error bars represent the mean ± SD.microbial infection. Here, we examined the role of MCs in mobi-
lizing DCs during bacterial infection, employing multiple experi-
mental models of E. coli infection and its resulting effect on the
host’s primary adaptive immune response.
RESULTS
MCs Contribute to the Primary Humoral Immune
Response to Bacterial Infection
In light of the several lines of evidence pointing to a possible role
for MCs in modulating primary adaptive immune responses to
infection, we investigated the ability of a primary immune
response evoked during challenge with uropathogenic E. coli
strain, J96, by WT or MC-deficient mice to protect against
a subsequent E. coli challenge. Because the innate immune
system of MC-deficient mice is inherently compromised (Echte-
nacher et al., 1996; Malaviya et al., 1996), it was not possible to
directly use MC-deficient mice for secondary challenge studies,
as it would be difficult to distinguish between observations
attributable to the innate or adaptive immune systems. Recently,
Thumbikat et al. demonstrated the protective capacity of E. coli-
specific serum antibodies by infusing them into naive mice and
then showing that these passively immunized mice exhibited
increased resistance to E. coli-induced bladder infections
(Thumbikat et al., 2006). We attempted a similar experiment to
investigate the protective potential of the primary humeral
immune response after E. coli challenge, developed in MC-suffi-
cient or -deficient hosts. For this experiment, we infused sera332 Cell Host & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevcollected from MC-deficient mice (Wsh) and WT mice 14 days
following footpad infection by E. coli labeled with trinitrophenol
(TNP) to serve as a unique antigen. We found that TNP-specific
titers of antibodies in E. coli-infected WT mice were significantly
higher than those observed in infected MC-deficient mice
(Figure 1A). These sera, as well as sera obtained from uninfected
WT and MC-deficient mice, were then passively transferred to
naive female mice by peritoneal injection before intravesicular
challenge with 13 108E. coli J96. As shown in Figure 1B, bacte-
rial numbers in the bladders of mice immunized with sera from
WT mice were significantly reduced compared to controls,
whereas this was not the case in mice that were immunized
with sera from MC-deficient mice. Therefore, the antibody
response evoked in MC-deficient mice is not only reduced, it is
also less protective than that of WT mice.
To verify the contribution of MCs to the development of
primary humoral responses to E. coli, we compared the time
course of the development of IgM and IgG antibodies in WT
and MC-deficient mice following infection in a footpad model
of infection. TNP-labeled E. coli was injected, as previously
described, into the footpads of WT, MC-deficient (W/Wv), or
control MC-deficient mice whose footpads had been repleted
with WT MCs. After 7, 14, or 21 days, serum was collected and
analyzed for TNP-specific IgM and IgG. Within 7 days, TNP-
specific IgM had reached its maximal levels inWTmice, followed
by a rapid decrease by 14 days (data not shown). Similarly, TNP-
specific IgGwas detected inWTmice by 7 days but continued to
increase until it reached maximal levels by 14 days (Figure 1C).ier Inc.
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TNP-specific IgM or IgG in the same time course (data not shown
and Figure 1C, respectively). Reductions in total TNP-specific
IgG in MC-deficient mice were reflected in all TNP-specific IgG
isotypes relative to WT controls (data not shown), and repletion
of MC-deficient footpads with MCs repaired the ability of these
mice to generate TNP-specific antibody responses to levels
seen in WT controls (Figure 1C). These data suggest that the
observed protective benefit of sera from MC-sufficient animals
in the UTI challenge model may lie in the presence of increased,
pathogen-specific antibody titers.
Because MC-derived TNF has been implicated in trafficking
immune cells, we also investigated the specific contribution of
this cytokine in the humoral immune response. We challenged
TNF/ or WT-MC footpad-repleted MC-deficient mice with
TNP-labeled E. coli and compared their humoral responses.
We found that TNP-specific IgG in TNF/MC footpad-repleted
MC-deficient mice was significantly less than in MC-deficient
mice with WT-MC-repleted footpads (Figure 1D). Collectively,
these results reveal the vital role of MCs and MC-derived
TNF in promoting primary humoral responses during bacterial
infection.
MC-TNF Elicits Recruitment of DCs to Sites of E. coli
Infection
Because it has been shown that MCs and MC-TNF promote the
migration of epidermal LCs from the skin to DLNs following IgE-
mediated activation (Bryce et al., 2004; Jawdat et al., 2004), we
hypothesized that one way that MC-TNF may function to
enhance adaptive immune responses during infection could be
by inducing DCmigration to DLNs. To investigate this possibility,
we continued to use the footpad injection model for our primary
challenge, injecting 1 3 105E. coli J96 or saline control into the
footpads of mice. After 3 hr, we examined cross-sections of
mouse footpads for DC density and distribution by confocal
microscopy. Surprisingly, we did not see a substantial change
in the distribution of MHC Class II+ LCs in the epidermal region
of the footpad (Figure 2A). However, compared to saline
controls, we noticed a striking increase in MHC Class II+ cells
in the dermis around blood vessels (Figure 2A). These cells
were found to be positive for DC markers such as CD11c and
CD11b, but not for the macrophage marker F4/80 (Figure S1
available online). We confirmed that DCs were being recruited
into the infection site using flow cytometry to analyze single-
cell suspensions of the footpad positive for the DC marker
CD11c. By 3 hr after infection, we noted a significant recruitment
of DCs (2.3-fold more than controls), which persisted for 12 hr
before subsiding by 40 hr (Figure 2B).
To confirm that MCs were active during DC recruitment after
E. coli challenge, we stained tissue sections with Alexa-488-
coupled avidin, which binds theMC granule component heparin.
As shown in Figure 2A, MCs are well represented in the dermis,
proximal to blood vessels in saline-challenged tissues. However,
in E. coli-challenged footpad tissues, MCs are less evident, sug-
gesting that they have released their granule contents (Figures
2A and S1D). To demonstrate that MCs and MC-derived TNF
are required for DC recruitment into inflamed tissue, we injected
E. coli into footpads of MC-deficient mice or deficient animals
whose footpads had been repleted with WT or TNF/ MCs.Cell HoAs indicated in Figure 2C, both MC-deficient mice and MC-defi-
cient mice repleted with TNF/ MCs failed to recruit DCs into
the footpad by 3 hr, in contrast with MC-deficient mice repleted
withWTMCswhere significant recruitment occurred (Figure 2C).
These observations suggest that the recruitment of DCs
observed at sites of E. coli infection is critically dependent on
MC-TNF.
Because DCs are heterogeneous, with distinct subsets
exhibiting differing functional capabilities, it was of interest to
identify the principle DC subsets recruited into E. coli-infected
tissue. Single-cell suspensions were prepared from saline- or
E. coli-challenged footpads and assessed by flow cytometry
employing antibodies against an assortment of DC surface
markers (Table 1). This analysis allowed us to classify four DC
subsets, designated FP-DC regions 1–4 (Table 1 and Figure 2D)
(Leon et al., 2007). Additional markers such as MHC Class II
were also examined and are included in Figure S2. Comparison
of the total numbers of each DC subset in the footpads 3 hr
after challenge with either saline or E. coli revealed that a popula-
tion of DCs that exhibits a phenotype of CD11cmid CD11b+ GR1
(FP-R4) (Table 1 and Figure 2E) was substantially increased in
response to E. coli challenge. A second subset of DCs that
possessed a phenotype consistent with monocyte-derived
DCs, CD11c+CD11b+GR1+ (FP-R1) (Leon et al., 2007), also
increased but only represented about 2% of the total FP-DC
population (Table 1 and Figure 2E). Intriguingly, when we exam-
ined all four DC subsets for surface expression of the DLN-
homing chemokine receptor, CCR7, only the FP-R1 and FP-R4
subsets were significantly positive 12 hr after E. coli challenge
(Figure S3). Taken together, these data reveal that MCs and
MC-TNF recruit at least two DC subsets into the site of infection,
and these cells subsequently acquire the capability to traffic to
the DLNs.
MC-TNF Induces E-Selectin Expression on Vascular
Endothelium, and E-Selectin Blockade Impairs DC
Accumulation in Infected Tissues
Although MC-TNF appears to influence DC trafficking into the
tissue, it is unclear, mechanistically, how this occurs. TNF is
known to induce the expression of adhesion molecules on blood
vessel endothelium required for the recruitment of leukocytes
into tissues (McHale et al., 1999). Therefore, we hypothesized
that MC-TNF triggers the expression of adhesion molecules on
blood vessel endothelium required for the recruitment of DCs
into infected tissues. Confocal analysis of tissue sections
derived from E. coli-injected WT footpads revealed that several
adhesion molecules, including E-selectin (CD62E), P-selectin
(CD62P), ICAM-1, ICAM-2, and V-CAM were well expressed
(data not shown). However, the most dramatic response 3 hr
after E. coli challenge occurred with increases in E-selectin on
blood vessel endothelium (Figure 3A). Of interest, this dramatic
enhancement of E-selectin expression by 3 hr parallels the
recruitment of DCs into the footpad (Figures 2A and 2B). To
determine whether MC-TNF was required for the induction of
E-selectin on footpad blood vessel endothelium, we challenged
footpads of WT, MC-deficient, and MC-deficient mice repleted
with WT or TNF/MCswith E. coli or saline. After 3 hr, footpads
were collected, sectioned, and stained for E-selectin and CD31
(a marker of blood vessel endothelium). Confocal microscopyst & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc. 333
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Mast Cells Augment Adaptive ImmunityTable 1. DC Characterization in the Footpad
DC Subsets Markers Subset
Total
Numbers: Saline
Percent
Total DC: Saline
Total Numbers:
E. coli
Percent Total
DC: E. coli P Valuea
Monocyte-derived
DCs
CD11c+CD11bhiGR1+
(Leon et al., 2007)
FP-R1 26 ± 17 1.2% 90 ± 36 1.9% 0.0007
CD11blo DCs CD11c+CD11bloGR1 FP-R2 831 ± 279 35.5% 1316 ± 194 29% 0.002
CD11chi DCs CD11chiCD11bhiGR1 FP-R3 675 ± 265 30% 897 ± 180 19.5% 0.085
CD11cmid DCs CD11cmidCD11bhiGR1 FP-R4 779 ± 256 33.3% 2320 ± 585 49.5% 0.00001
aP values comparing total numbers within each DC subset from saline- and E. coli-challenged samples using Student’s t test.analysis revealed that E. coli challenge induced a 5.2-fold
increase in the percentage of detectable blood vessel segments
expressing E-selectin in WT tissue versus saline controls
(Figure 3B). Comparably, E. coli challenge of MC-deficient or
TNF/ MC-repleted MC-deficient footpads only induced
a 2.5- or 2.6-fold induction of E-selectin expression on endothe-
lial segments over saline controls, respectively (Figure 3B). In
contrast, challenge of WT-MC-repleted MC-deficient footpads
with E. coli resulted in a significant 4.25-fold increase in detect-
able E-selectin on endothelial segments that was comparable to
WT controls (Figure 3B). Thus, MC release of TNF induces
optimal expression of E-selectin on blood vessel endothelium
during infection.
To establish the relevance of MC-TNF-induced increases of
E-selectin on blood vessel endothelium to DC migration during
infection, we examined DC migration within the context of
E-selectin blockade.We hypothesized that infusion of antibodies
against E-selectin would block the recruitment of DC subsets
into the footpad. To assess this, we first injected mice with
a monoclonal anti-E-selectin blocking antibody 2 hr prior to the
injection of E. coli or saline in the footpad. Examination of
footpad sections in mice injected with anti-E-selectin revealed
that the antibody could be colocalized on footpad CD31+ endo-
thelium by 3 hr and was detectable even at 24 hr (data not
shown). We observed that E-selectin blockade profoundly inter-
feres with E. coli-induced DC accumulation in the footpad
(Figure 3C). We also examined whether E-selectin blockade
was selective against particular DC subsets; however, we
observed that it was uniformly effective against all recruited
DC subsets (Figure 3D). These results indicate that MC-TNF-
induced E-selectin expression on vascular endothelium medi-
ates the influx of DCs into infected tissue sites.
MC-TNF Promotes Accumulation of DCs in DLNs
following Infection
Because the primary immune response is dependent on the
migration of antigen-bearing DCs from infected sites to theCell HosDLNs, we examined the role for MCs and MC-TNF in the
accumulation of DCs in the DLNs. Examination of single-cell
preparations of the popliteal DLNs at 12 hr after E. coli challenge
demonstrated a significant (3-fold) increase in the total number
of DCs (identified as CD11c+ and MHC Class II+) compared to
saline controls (Figure 4A). A maximal 7-fold increase in total
DCs compared to saline controls was detected at 24 hr, followed
by a substantial drop by 48 hr (2-fold increase compared to
saline controls) (Figure 4A). To determine whether MCs
contribute to DC accumulation in DLNs, we injected E. coli into
the footpads of WT, W/Wv, or WT-MC footpad-repleted MC-
deficient mice. After 24 hr, single-cell suspensions of DLNs
were acquired and examined for total numbers of DCs. A signif-
icant deficiency in DC accumulation in the DLNs of MC-deficient
micewas observed, compared toWT controls or toMC-deficient
mice repleted with MCs (Figure 4B). The reduced DC accumula-
tion observed inMC-deficientmicewas not due to a deficiency in
tissue resident DCs (data not shown). It is also noteworthy that
MC-dependent DC accumulation also correlated with optimal
lymphocyte accumulation (McLachlan et al., 2003) (data not
shown). Similar data were obtained in a UTI model, revealing
that MCs are required for the optimal accumulation of DCs in
the iliac DLNs after infection with E. coli in the bladder
(Figure S4), thus illustrating that MCs influence DC migration in
two separate models of E. coli infection.
To investigate the contribution of TNF to the mobilization of
DCs into DLNs, we compared DC numbers in DLNs of WT and
TNF/ mice following E. coli or saline challenge. A significant
deficiency was observed in total DCs in the DLNs of TNF/
animals, relative to WT controls (Figure 4C). This mobilization
defect was not due to an absence of footpad DCs or MCs in
TNF/ mice, as the numbers of both cell types are comparable
to those found in WT mice (data not shown). To determine
whether the TNF involved in DC accumulation was MC derived,
we compared DC numbers in MC-deficient mice that were
repleted with MCs from WT or with TNF/ mice. We found
that, in contrast to MC-deficient mice repleted with WT-MCs,Figure 2. Challenge of Footpads with E. coli Induces an MC-TNF-Dependent Increase in DC Numbers
(A) Analysis of WT footpad, 3 hr after injection of E. coli or saline, for MHC Class II (DCs), CD31 (blood vessel endothelium), and avidin (MCs) by confocal micros-
copy. Scale bars = 100 mM. E = epidermis, D = Dermis, LC = Langerhans cells (arrowheads). The arrow denotes a DC bundle.
(B) Total number of CD11c+ DCs in single cell suspensions of footpads at the indicated time-points. N = 4-5 for each time-point. *p < 0.05 compared to saline
controls. Data was analyzed for statistical significance with one-way ANOVA and Tukey’s posttest.
(C) Total number of CD11c+ DCs in single cell suspensions of W/Wv, WT-MC or TNF/MC repletedW/Wv footpads, 3 hr after saline or E. coli challenge. N = 4 for
each sample. *p < 0.05 compared to saline controls and **p < 0.05 comparing E. coli challenged WT-MC repleted W/Wv footpad samples to W/Wv and TNF/
MC-repleted W/Wv samples. Data was analyzed for statistical significance with one-way ANOVA and Tukey’s posttest.
(D) The gating strategy to identify footpad (FP)-DC subsets. The table inset identifies each subset.
(E) Total number of each FP-DC subset, regions 1-4, 3 hr after saline or E. coli challenge. N = 6. *p < 0.05 comparing E. coli challenged samples to saline controls
within each FP-DC subset. Data was analyzed for statistical significance using unpaired Student’s t test. Error bars represent the mean ± SD.t & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc. 335
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(A) Total number of CD11c+/MHC Class II+ DCs in
single-cell suspensions of DLN at 12, 24, or 48 hr
after saline or E. coli challenge. n R 10 DLNs for
each time point. *p < 0.05 compared to saline
controls; **p < 0.05 comparing the 24 hr to the 12
and 48 hr E. coli-challenged samples.
(B) Total number of DCs in single cell suspensions
of DLNs of WT, W/Wv, and WT MC-footpad
repleted W/Wv mice 24 hr after challenge with
saline or E. coli. N = 6 for WT and W/Wv samples.
N = 4 for MC-repleted W/Wv samples. *p < 0.05
compared to saline controls. **p < 0.05 comparing
E. coli-challenged MC-sufficient samples to the
E. coli-challenged W/Wv samples.
(C) Total number of DCs in single-cell suspensions
of DLNs of WT and TNF/ mice 24 hr after chal-
lenge with saline or E. coli. n = 4 for each sample.
*p < 0.001 compared to saline controls; **p < 0.001
comparing E. coli-challenged samples.
(D) Total number of DCs in single-cell suspensions
of DLNs of WT-MC-repleted W/Wv and TNF/
MC-repleted W/Wv mice 24 hr after challenge
with saline or E. coli. n = 4 for each sample. *p <
0.001 compared to saline controls; **p < 0.001
comparing E. coli-challenged samples.
Data in (A)–(D) were analyzed for statistical signifi-
cance with one-way ANOVA and Tukey’s posttest.
Error bars represent the mean ± SD.TNF/ MC-repleted MC-deficient mice evoked markedly
reduced levels of DC accumulation into DLNs (Figure 4D). There-
fore, as in the footpad, MC-derived TNF is required for the
recruitment of DCs into DLNs.
Though our data suggest that MC-TNF controls DC accumu-
lation in DLNs through its influence on E-selectin expression
on blood vessel endothelium at the site of infection, it is distinctly
possible that MC-TNF might also influence DC trafficking to
DLNs by acting on the distal DLN environment. Key chemokines
known to influence this migratory pattern are CCL21 and CCL19,
which are ligands for the surface receptor CCR7 (Gunn et al.,
1999). First, we examined the effects of anti-CCL21 or anti-
CCL19 blockade on DC accumulation in DLNs after infection
with E. coli. Anti-CCL21 blockade significantly interfered with
DC and lymphocyte accumulation in DLNs compared to controls
(Figure S5A), whereas anti-CCL19 blockade had no effect
(Figure S5B). Therefore, we focused on the ability of MC-TNFCell Hosto alter CCL21 levels during infection. To examine this, we first
challenged WT footpads with E. coli and then analyzed DLNs
at various time points for the expression of CCL21 by ELISA.
Injection of E. coli into footpads demonstrated that CCL21 levels
are significantly increased in the DLNs by 3 hr and remained
elevated for up to 12 hr (Figure S5C). This increased CCL21
expression could be localized to cells present in the T cell zones
of DLNs of mice challenged with E. coli, but not in saline-chal-
lenged mice (Figure S5D). To determine whether MC-TNF is
required for the induction of CCL21 in the DLN, we injected
E. coli into the footpads of MC-deficient mice and MC-deficient
mice repleted with TNF/ MCs or WT MCs. Total protein was
collected from DLNs after 3 hr and analyzed for the expression
of CCL21. Although CCL21 was detectable in the DLNs of all
of these mice, MC-deficient and TNF/ MC-repleted MC-defi-
cient mice were unable to induce CCL21 to the higher levels
observed in WT MC-repleted W/Wv mice controls (Figure S5E).Figure 3. MC-TNF Is Required for the Optimal Induction of E-Selectin Expression after Challenge with E. coli
(A) Analysis of WT footpad tissue for E-selectin, CD31 (blood vessel endothelium), and avidin (MCs) by confocal microscopy. E, epidermis; D, dermis. Scale bar,
100 mM. (Arrows) CD62E+ endothelial segments. Similar results were obtained in three separate experiments.
(B) Enumeration of E-selectin+ blood vessel segments in 700 mM 3 700 mM confocal images derived from 10 mM sections of WT, W/Wv, or WT-MC or TNF/
MC-repleted W/Wv footpads 3 hr after saline or E. coli challenge. Data are represented as the E. coli-induced fold increase in the percent of E-selectin+ blood
vessel segmentscompared tosaline-treatedcontrols. n=25–30fields fromthreeseparateexperiments. *p<0.05and **p<0.05,comparingWTorWT-MC-repleted
W/Wv samples to W/Wv or TNF/MC-repleted W/Wv samples, respectively.
(C) Total numberofCD11c+DCs in single-cell suspensionsof footpad3hr after challengewith salineorE. coli. n = 5. *p<0.05compared to salinecontrols; **p<0.05
comparing E. coli challenged samples.
(D) Total number of each FP-DC subset, regions 1–4, from mice treated with anti-E-selectin or Rat IgG1 3 hr after challenge with saline or E. coli. n = 5. *p < 0.05
comparing E. coli-challenged samples to saline controls within each FP-DC subset; **p < 0.05 comparing E. coli-challenged samples from anti-E-selectin to rat
IgG1-treated mice within each FP-DC subset.
Data in (B)–(D) were analyzed for statistical significance with one-way ANOVA and Tukey’s posttest. Error bars represent the mean ± SD.t & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc. 337
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that facilitate the enhanced migration of DCs, not only into the
infected tissue site, but also into the DLNs.
Kinetics of DC Recruitment into Infected Tissues
and Ensuing Migration to DLNs
Ourdata suggest that themajority ofDCs reaching theDLNs from
the infected sites are not originally tissue resident but recently
recruited from the circulation. To clarify the nature of DC traf-
ficking from the infected tissue to the DLN, we labeled all of the
cells in the footpad with the intravital dye CFSE (Legge and
Braciale, 2003) and examined DC trafficking to the DLN after
E. coli infection of the footpads. The instilled dose of CFSE was
carefully titrated to ensure that all of the cells in the footpads
were labeled without any excess CFSE label reaching the DLN.
In this model, we expect that, if most of the DCs that accumulate
in the DLN during infection are derived from DCs resident to the
footpad, then the majority of DCs should be labeled with CFSE.
In contrast, if the majority of DCs are only transiently present in
the tissue and recruited from the bloodstream into the tissue
site in response to infection prior to their egress to the DLN,
then we expect relatively few of the DCs in the DLN to be labeled
with CFSE.
As shown in Figure 5A, injection of 1 3 106 mmols of CFSE
directly into the footpadfluorescently labels all of thecells present
in the footpad, including the tissue resident DCs. After 4 hr, E. coli
or saline was instilled into CFSE-labeled footpads, and DLNs
were acquired after 24 hr and analyzed for total CFSE+ DC
numbers. As demonstrated in Figure 5B, 8.7% of the DCs that
accumulate in the DLN after E. coli challenge are labeled with
CFSE, indicating that the majority of the DCs in the DLN were
not resident to the footpad at the time of bacterial challenge.
We undertook several controls to validate our experimental
model and support the origin of our DC population as being
nontissue resident yet having trafficked through the infected
tissue. Importantly, non-DCs in the DLN remained unlabeled
after 24 hr, establishing that CFSE did not drain into the DLN
and nonspecifically label cells (Figure 5B). CFSE-labeled DCs
accumulated in T cell zones of DLNs (data not shown) with
a time course commensurate with that observed in Figure 5A,
supporting the assumption that CFSE itself does not interfere
with the ability of DCs to traffic in a normal manner (data not
shown). Because there are two routes of entry for DCs into
DLNs, through high endothelial venules (HEVs) or through the
tissue-draining lymphatics, it was also necessary to rule out the
possibility that the majority of DCs within the DLN had trafficked
into the DLN through the HEVs. Both plasmacytoid DCs (pDCs)
and CD8a+ DCs are thought to enter the DLNs via the HEVs,
and furthermore, pDCs may represent up to 70% of the total
DC population in the DLNs of some mouse strains (Asselin-
Paturel et al., 2001; Nakano et al., 2001). To clarify this, we exam-
ined DLN single-cell suspensions from WT mice for pDCs
(CD11c+/CD11blo/B220+) and CD8a+ DCs (CD11c+/CD11blo/
B220/CD8a+), which we found to collectively represent 10.9%
and 15.6% of the total DC populations in saline- and E. coli-chal-
lenged mice, respectively (Figure S6). Most of the recruited DCs
appeared in the CD11c+/CD11bhi/GR1 and CD11c+/CD11bmid
subsets (Figure S6). In addition, extensive quantitative assess-
ment of sections of DLNs 3, 6, 12, and 24 hr after challenge338 Cell Host & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevwith E. coli revealed that CD11c+ and CD11b+ cells traversing
or in the lumen of HEVs are rare (<.5 CD11c+ cells/HEV at 3, 6,
12, and 24 hr) (Figure S7). Taken together, these data validate
our assumption that the relevant DC populations traffic through
the site of infection and support the use of the CFSE labeling
strategy to characterize the pattern of DC migration through
infected footpad tissue.
To more effectively capture the DCs trafficking into the DLNs,
which are presumably recently recruited DCs into infected sites,
we labeled the footpad with CFSE 6 or 12 hr after challenge with
E. coli or saline. By introducing the label-significant periods after
bacterial challenge, we expected to label recently recruited DCs
in the footpad. We found that the accumulation of CFSE+ DCs
after 24 hr was 5% and 7%, respectively (Figure 5C), a minority
of the DC pool. This finding led us to hypothesize that the traf-
ficking of recently recruited DCs to the DLNs was a gradual
and continuous process, rather than a single large bolus move-
ment. To test this, we gave successive injections of CFSE at 0,
6, and 12 hr (multiple labels) after E. coli challenge to seewhether
it could induce a proportional increase in the number of CFSE+
DCs accumulating in the DLN. As demonstrated in Figure 5C,
a significant 3-fold increase in the total number of CFSE-labeled
DCs was seen in the DLN at 24 hr (27.2% ± 13.7%) compared to
saline challenge (8.6% ± 4.2%). Cumulatively, our observations
support the notion that, following infection, DC recruitment
into the infected site followed by egress into the DLN via the
lymphatics occurs as a piecemeal and continuous process
over an extended period of time.
Blockade of DC Recruitment into Infection Sites Impairs
Development of Primary Adaptive Immune Responses
Taken together, our data suggest that, during E. coli infection,
MC-released TNF induces the expression of E-selectin on the
endothelium of local blood vessels, allowing influx of blood-
stream-derived DCs, and these recently recruited cells subse-
quently migrate to DLNs, initiating the development of a primary
adaptive immune response. As such, we predicted that blockade
of E-selectin expression at sites of infection should abrogate DC
influx into these sites and ultimately into the DLNs and impair
the development of the primary humoral response. We found
that pretreatment with E-selectin-specific, but not control, rat
IgG1 antibody significantly impaired the recruitment of total
DCs into the DLNs following footpad challenge with TNP-labeled
E. coli (Figure 6A). Importantly, we were unable to detect the
expression of E-selectin on the endothelium of the DLN at 3
(Figure 6B), 6, 12, or 24 hr (data not shown) after infection with
E. coli, confirming that E-selectin blockade of DC recruitment
into the DLN was the result of its activity in the footpad. In addi-
tion, administration of anti-E-selectin antibodies specifically
blocked the development of TNP-specific humoral immune
responses (Figure 6C). Collectively, our data suggest that MCs
modulate the primary adaptive immune response during bacte-
rial infections by inducing the recruitment of circulating DCs
into sites of infection and, subsequently, into the DLNs.
DISCUSSION
We have shown that, during E. coli infection, tissue resident MCs
play a critical role in drawing blood-borne DCs into infected sites,ier Inc.
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Figure 5. E. coli Infection Induces the Continual and Serial Migration of DCs from the Bloodstream through the Footpad prior to Their Egress
to the DLN
(A) CFSE or vehicle was injected into footpads. After 4 hr, single-cell footpad suspensions were stained with anti-CD11c and analyzed by flow cytometry.
(B) CFSE or vehicle was injected into footpads. After 4 hr, footpads were injected with E. coli or saline. After 24 hr, single-cell suspensions of DLNs were analyzed
by flow cytometry for CFSE+ DCs (identified as CD11c+/MHC Class II+). (Top) The percentage of CFSE+ DCs in gated DC DLN populations. n = 4–6. p < 0.05
comparing saline to E. coli-challenged samples. (Bottom) The side scatter profile of the entire DLN population of each sample.
(C) Footpads were challenged with E. coli or saline. At the indicated times, CFSE or vehicle was injected into footpads. At 24 hr after saline or E. coli challenge,
DLN single-cell suspensions were stained for DCs (identified as CD11c+/MHC Class II+) and analyzed by flow cytometry. Histograms represent the percent of
CFSE+ DCs in gated DLN DC populations. (Top) CFSE or vehicle injected 6 hr after E. coli challenge. n = 6. p < 0.05 comparing saline to E. coli-challenged
samples. (Middle) CFSE or vehicle injected 12 hr after E. coli challenge. n = 6. p < 0.05 comparing saline to E. coli-challenged samples. (Bottom) CFSE or vehicle
was injected 4 hr before and 6 and 12 hr (‘‘Multiple Label’’) after E. coli or saline challenge. n = 6. p < 0.05 comparing saline to E. coli-challenged samples.
All data were evaluated for statistical significance using unpaired Student’s t test.prior to their egress into secondary lymphoid organs, where they
function to augment adaptive responses. In contrast to other
models, which have shown a tissue resident origin of those
antigen-presenting cells mobilized byMCs in response to inflam-
matory stimuli (Bryce et al., 2004; Jawdat et al., 2004, 2006; SutoCell Hoet al., 2006), we find that nontissue resident DCs derived from the
bloodstream, primarily with a CD11cmidCD11b+GR1 pheno-
type, are recruited into infection sites prior to their egress to
DLNs. In our infection model, we observed that the trafficking
of DCs through infected tissues and into the DLN does notst & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc. 339
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Mast Cells Augment Adaptive Immunityinvolve bulk flow but occurs in an incremental and continuous
manner. This could reflect the previously reported piecemeal
activation response of MCs to infecting E. coli (Malaviya et al.,
1994) and the ensuing MC-initiated changes to the vascular
endothelium, such as the observed upregulation of E-selectin
and culminating in the continual recruitment of new DCs into
infected tissues. In spite of the continual flow of DCs into
DLNs, it is noteworthy that maximal DCmovement was achieved
by 24 hr, which coincides with the previously reported time
frame for maximal sequestration of circulating lymphocytes in
the DLN following E. coli infection, a trafficking response also
mediated by peripheral MCs (McLachlan et al., 2003). Therefore,
during E. coli infections, tissue resident MCs appear to regulate
the coordinate mobilization into the DLNs of both DCs
and T cells, the two cell types principally involved in the induction
of primary immune responses. Coincident mobilization of
antigen-presenting DCs and T cells into DLNs should greatly
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Figure 6. E. coli Infection Induces E-Selec-
tin-Dependent Increases in DCs in DLNs
and Humoral Responses
(A) Total number of MHC Class II+/CD11c+ DCs in
the DLNs of anti-E-selectin or rat IgG1-treated
mice 24 hr after challenge with saline or E. coli.
n = 3–5. Data were analyzed for statistical signifi-
cance with one-way ANOVA and Tukey’s posttest.
*p < 0.05 compared to saline controls; **p = 0.01
comparing E. coli-challenged samples.
(B) Confocal analysis of 10 mM sections derived
fromWTDLNs 3 hr after E. coli challenge. Sections
were stained for anti-E-selectin, anti-PNAD (high
endothelial venules), and anti-CD11c (DCs). Scale
bar, 100 mM. The boxed inset is represented in
the image to the right. Scale bar, 20 mM. Similar
results were obtained in three separate experi-
ments.
(C) GMT of TNP-specific serum IgG in TNP E. coli-
challenged mice treated with anti-E-selectin or rat
IgG1. n = 5 for each group. Significance between
saline and E. coli-challenged samples was evalu-
ated using ANOVA with Tukey’s posttest. *p =
0.001. Error bars represent the mean ± SD.
enhance the probability of interaction
between antigen-presenting DCs and
naive antigen-specific T cells. The func-
tional relevance of MC-mediated immune
cell trafficking into DLNs is illustrated by
the finding that, compared to WT mice,
titers and protective abilities of humoral
antibodies produced in MC-deficient
mice are significantly diminished (Fig-
ure 1). These results and our interpreta-
tion could explain why, after primary
challenge, we observed that sera derived
from WT mice offered significantly more
protection than sera from MC-deficient
mice when recipient mice were chal-
lenged in the urinary tract with E. coli
(Figure 1). Potentially, MCs can enhance
protective adaptive immune responses
not only to E. coli in the footpad and UTI models of infection,
but also in many body sites and, likely, in response to a range
of pathogens.
MCs are located at host-environment interfaces, but many
MCs are also found lining the host vasculature (Marshall and
Jawdat, 2004). TNF, which is typically prestored within MC gran-
ules and released immediately after MC activation, is well known
for promoting vascular permeability (Bradley, 2008). Previously,
TNF from peripheral MCs was identified as the primary MC
determinant responsible for mediating increased sequestration
of lymphocytes in DLNs following infection, likely acting, at least
in part, through the upregulation of the vascular cell adhesion
molecule-1 (VCAM-1) on high endothelial venules (McLachlan
et al., 2003). Here, we demonstrated that the influx of specific
subsets of circulating DCs into sites of infection was mediated
by MC-TNF through its action both at the site of infection
and in the distal DLNs. We see that MC-TNF induces both340 Cell Host & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc.
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neighboring blood vessels in the site of infection and enhanced
CCL21 production in the DLN. The contribution of E-selectin to
the entry of DCs into infection sites and the contribution that
these cells play to the developing immune response was evident
from the finding that a monoclonal antibody directed at E-selec-
tin could not only block the influx of DC subsets into sites of
infection, but also significantly reduce the primary immune
response to infection. MC-TNF was also found to enhance
expression of the CCL21 chemokine in the DLN after E. coli chal-
lenge. Presumably, MC-TNF acts by flowing into the DLN and
activating TNFR+ stromal or endothelial cells to increase their
expression of CCL21. This remote control mechanism, first
suggested for the MCP-1 chemokine (Palframan et al., 2001),
may be a major mechanism by which the inflammatory state of
the peripheral tissue is communicated to the DLN environment.
Collectively, these data emphasize the combinatorial function
of MC-TNF targets to optimize DC trafficking through infected
sites and to the DLN.
Finally, in contrast to other models of inflammation that indi-
cate that MCs have a limited role in the development of primary
immune responses or that they have primarily a pathological role
(Galli et al., 2005), our data suggest that MCs play a key role in
the development of primary immune responses to infection.
Although the adaptive immune response evoked here in our
studies is largely cleared by the innate immune response before
the humoral response is detectable, this response will likely
confer protection to the host during subsequent E. coli infections
and may be particularly important in the UTI model, where
a reservoir of persistent bacteria can remain after innate clear-
ance (Mysorekar and Hultgren, 2006). Nevertheless, these
results expand our view of tissue residentMCs by extending their
known sphere of influence. MCs appear not only to act locally
within the site of infection through innate recognition of patho-
gens, but also, they amplify adaptive immunity indirectly through
the recruitment of DCs. In this way,MCs function both in the local
site of infection and the distal DLN to promote pathogen control
and, similarly, act with a broad temporal scope, being one of
the first cells to respond to invading pathogens yet greatly
influencing the long-term immunological memory to pathogens.
This recognition could potentially be harnessed for immunopro-
phylactic or therapeutic purposes against harmful infectious
diseases.
EXPERIMENTAL PROCEDURES
Mice and MC Reconstitutions
Male MC-deficient WBB6F1-W/Wv mice, congenic littermate control
WWB6F1-+/+mice,MC-deficientWsh/Wshmice, TNF/ (B6;129S6-Tnftm1Gk1)
mice, and B6129SF2/J controls were from Jackson Laboratories. TNF/mice
on aC57BL/6 backgroundwere purchased fromB&KUniversal. C57BL/6mice
were obtained from the NCI production facility. Mice were housed in the Duke
University Vivarium until experiments were performed. For reconstitutions,
MCs were prepared and transferred into the footpads of recipient mice as
described in the Supplemental Experimental Procedures. All experimental
protocols were approved by the Duke University Institutional Animal Care
and Use Committee.
Reagents
Labeled and unlabeled antibodies against MHC Class II (Clone M5/114.15.2),
CD8a (Clone 53-6.7), CD11b (Clone M1/70), CD11c (Clone HL3), CD19 (CloneCell Ho1D3), CD40 (Clone HM40-3), CD86 (Clone GL1), B220 (Clone RA3-6B2), GR1
(Clone RB6-8C5), F4/80 (Clone BM8), and CCR7 (Clone EBI-1) were from
e-Biosciences or BD Biosciences. Polyclonal anti-Kit, anti-CCL21, and anti-
CCL19 were from R&D Systems. Anti-CD62E (clone 9A9) was a kind gift
from Klaus Ley (University of Virginia, Charlottesville, VA). The 2,4-carboxy-
fluorescein di-succimidyl-ester (CFSE) and Alexa-488-labeled avidin are
from Molecular Probes. All secondary isotype-matched controls are from BD
Biosciences. All polyclonal controls are from Jackson ImmunoResearch.
Footpad Infection Model
For humoral or DLN studies, 13 106 TNP-labeled E. coli strain J96 or 1 3 105
unlabeled E. coli strain J96 was subcutaneously injected into footpads in
a 20 ul volume, respectively. E. coli was labeled with TNP as described in
the Supplemental Experimental Procedures. For anti-CD62E blocking studies,
100 mg of the 9A9 monoclonal was injected into the tail vein 2 hr prior to E. coli
or saline challenge.
Urinary Tract Infection Model
UTIs in mice were established by instilling 13 108 J96 E. coli in a 30 ml volume
into the bladder through a catheter inserted into the ureter of anesthetized
female mice. For protection studies, 150 ml serum from E. coli-immunized
mice was intraperitoneally injected into recipient WT female mice 24 hr prior
to bladder challenge with J96 E. coli. After 24 hr, bladders were collected
from sacrificed mice and homogenized in 0.5% Triton-X in PBS with three
pulses of a Fastprep 120 rotary tissue homogenizer (Thermo). Samples were
diluted and plated onto MacKonkey agar plates. Total colony-forming units
of E. coli were evaluated by counting.
Immunofluorescence and Confocal Analysis
Prepared DLN or footpad sections were stained with labeled primary anti-
bodies as indicated. For CD11c staining, sections were labeled with anti-
CD11c (Clone HL3) followed by detection with biotinylated anti-hamster and
streptavidin-APC. Confocal images were obtained with a 3-Laser Nikon
Confocal Laser Scanning Instrument (Nikon Instruments). Images were
obtained using EZ-C1 Nikon software (Silver Version 2.01). Threshold values
were determined using the appropriate isotype-matched controls. A channel
series approach was used to ensure that there was no spectral overlap
between fluorescent signals.
Isolation and Flow Cytometric Analysis of Single-Cell Suspensions
of Footpads or DLNs
At the indicated times, footpads or DLNs were isolated and minced followed
by incubation in 100 U/ml Collagenase A (Sigma) for 30 min at 37C. Samples
were then pressed through a 70 mM cell-straining filter (BD Biosciences) and
washed. Samples were then incubated with the indicated antibodies to detect
DCs or DC subsets and were analyzed using a FACscalibur or LSRII flow
cytometer (BD Biosciences). For complete methods, see the Supplemental
Experimental Procedures.
DC Tracking Studies
CFSE or vehicle (13 106 mmols) was instilled into footpads in a 20 ml volume.
E. coli or saline was instilled after 4 hr. For post E. coli challenge labeling
studies, CFSEwas instilled at 0.753 106mmols in 20 ml at the indicated times
after saline or E. coli challenge. After 24 hr, single-cell suspensions of DLNs
were stained as indicated and analyzed by flow cytometry.
ELISAs
Blood was collected via the tail vein at days 7, 14, and 21 postchallenge.
Antigen-specific titers of anti-TNP IgM, IgG, or IgG isotypes were determined
by capture ELISA using TNP-OVA (Alexis) and anti-IgM, IgG, or IgG isotypes
(Southern Biotech). The data presented are the reciprocal log2 dilution of the
last sampleOD thatwas 2-fold higher than the naive sampleOD. Thegeometric
mean titer and standard deviation were calculated using the log2 endpoint
titers. Statistics were first performed on the log2 titers prior to conversion.
Statistical Analysis
Data were analyzed for statistical significance as indicated with one-way
ANOVA and Tukey’s posttest with Graphpad Prism or unpaired Student’s tst & Microbe 6, 331–342, October 22, 2009 ª2009 Elsevier Inc. 341
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Mast Cells Augment Adaptive Immunitytest with Microsoft Excel. Differences between groups were considered signif-
icant at p% 0.05.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
seven figures and can be found with this article online at http://www.cell.
com/cell-host-microbe/supplemental/S1931-3128(09)00313-8.
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